Albemarle drops 20.6% over past month as specialty chemicals lag materials
Question
Albemarle drops 20.6% over past month as specialty chemicals lag materials
Direct answer
Prolonged lithium price weakness drives multiple de-rating in Albemarle at $105.78 despite strong year-over-year forward consensus comparisons. — bearish pressure on ALB via specialty chemicals margin compression from lithium realized pricing.
- Original publisher
- Market Ontology
- Evidence through
- 2026-10-01
- Published
- 2026-10-20
- Revision
- 1 · 2026-10-20
Cite as: Market Ontology, “Albemarle drops 20.6% over past month as specialty chemicals lag materials”, revision 1, evidence through 2026-10-01. https://marketontology.com/catalysts/2026-10-01/albemarle-drops-20-6-over-past-month-as-specialty-chemicals-lag-materials-53b20e
| Asset | Direction | Timeframe | Channel | Score |
|---|---|---|---|---|
| ALB | ▼Bear | 1–4 weeks | specialty chemicals margin compression from lithium realized pricing | 67 |
Albemarle drops 20.6% over past month as specialty chemicals lag materials
Prolonged lithium price weakness drives multiple de-rating in Albemarle at $105.78 despite strong year-over-year forward consensus comparisons. — bearish pressure on ALB via specialty chemicals margin compression from lithium realized pricing.
Albemarle fell 1.71% to $105.78 and is down 20.6% over the past month.
- SourceAlbemarle fell 1.71% to $105.78 and is down 20.6% over the past month.
- TransmissionProlonged lithium price weakness drives multiple de-rating in Albemarle at $105.78 despite strong year-over-year forward consensus comparisons.
- SummaryAlbemarle shares fell 1.71% to $105.78, widening its trailing 30-day loss to 20.6%. The drawdown is more than double the Materials sector benchmark decline of 8.47%. Consensus forward estimates still reflect strong recovery comps with 1,442% projected EPS growth.
- ALBDirect directional or hedged short
Illustrative, not advice
- Crowded positioning may already reflect the move
- Counter-catalyst could neutralize the thesis before window closes
- ALB closes above pre-catalyst level on rising volume
- Catalyst narrative is officially walked back or contradicted
- Cross-asset confirmation (rates / FX / vol) reverses direction
- ALB price vs. pre-event level
- ALB volume vs. 20-day average
- Futures curve shape
- Inventory data
What happened next
Price follow-up pending — no stored daily closes for these assets yet.
Closing prices from stored daily bars; returns measured from the last close on or before the event date. Not a recommendation.
Sources
- Albemarle (ALB) Registers a Bigger Fall Than the Market: Important Facts to Note · Zacks Investment Research · 2026-09-30
Related catalysts
- 2026-10-17Albemarle Falls 2.84% to $95.39 as Chemical Specialty Multiple Contracts Before Q3ALB
- 2026-10-17Albemarle Falls 2.84% to $95.39 as Chemical Specialty Multiple Contracts Before Q3ALB
- 2026-10-17Albemarle drops to $95.39 as 1-month loss reaches 14.66% ahead of Nov. 4 reportALB LIT
- 2026-10-17Albemarle drops to $95.39 as 1-month loss reaches 14.66% ahead of Nov. 4 reportALB LIT
- 2026-10-13Albemarle Falls 2.73% to $98.51 Despite Forecasted Q3 EPS SurgeALB CPER-1.95%
- 2026-10-13Residential Solar Faces Severe Margin Compression on Weak Distributed DemandALB ENPH TAN
- 2026-10-13Albemarle Falls 13.8% in One Month as Rank Downgrade Tempers Q3 EPS OutlookALB
- 2026-10-13Albemarle Falls 2.73% to $98.51 Despite Forecasted Q3 EPS SurgeALB
See today's live cards
Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.